Gene: COX16
Official Full Name: cytochrome c oxidase assembly factor COX16provided by HGNC
Gene Summary: Involved in mitochondrial cytochrome c oxidase assembly. Located in mitochondrial inner membrane. Implicated in mitochondrial complex IV deficiency nuclear type 22. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO22809 | COX16 Knockout cell line (HeLa) | Human | COX16 | 1:3~1:6 | Negative | Online Inquiry |
KO22810 | COX16 Knockout cell line (HCT 116) | Human | COX16 | 1:2~1:4 | Negative | Online Inquiry |
KO22811 | COX16 Knockout cell line (HEK293) | Human | COX16 | 1:3~1:6 | Negative | Online Inquiry |
KO22812 | COX16 Knockout cell line (A549) | Human | COX16 | 1:3~1:4 | Negative | Online Inquiry |
COX16 Gene Knockout Cell Lines are specifically designed cellular models in which the COX16 gene has been knocked out, creating an invaluable tool for studying mitochondrial biology and its associated pathways. The COX16 gene plays a crucial role in the assembly of cytochrome c oxidase, a key enzyme in the electron transport chain involved in aerobic respiration. By utilizing these knockout cell lines, researchers can investigate the downstream effects of COX16 deficiency, elucidating its role in mitochondrial dysfunction and its implications in various metabolic disorders and diseases, including neurodegenerative disorders and cancer.
The mechanism of action involves the targeted disruption of the COX16 gene through CRISPR/Cas9 or other genome-editing technologies, resulting in the creation of stable cell lines devoid of functional COX16. This allows for the observation of altered mitochondrial dynamics, energy production, and apoptosis in a controlled laboratory setting, providing insights into metabolic adaptations and pathophysiological changes that are often difficult to study in whole organisms.
The scientific relevance of COX16 Gene Knockout Cell Lines extends to their applications in both research and clinical settings. They serve as crucial platforms for drug screening, and biomarker discovery, and investigating therapeutic targets. Researchers can exploit these cell lines to assess the efficacy of potential mitochondrial-targeted therapies, thereby accelerating the development of treatment options for diseases linked to mitochondrial dysfunction.
One of the key advantages of our COX16 Gene Knockout Cell Lines is their reliability and reproducibility, ensuring consistent results across experiments. Unlike alternative models that may express varying levels of the gene, our knockout lines offer a clean genetic background for studies focused on questioning the specific functions of the COX16 gene. Furthermore, the ease of use, combined with comprehensive product support, allows researchers to seamlessly integrate these models into their workflows.
We firmly believe that our COX16 Gene Knockout Cell Lines are an invaluable asset for researchers and clinicians dedicated to unraveling the complexities of mitochondrial biology. With a foundation built on scientific expertise and a commitment to quality, our company stands at the forefront of providing innovative biological products that empower discovery and advancement in life sciences.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.